Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0000950170-24-008020

President and CEO sold 91,052 shares at $20.23 ($1,841,982)

  • President and CEO acquired 91,052 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

WILSON TROY EDWARD · President and CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-24 Exercise or conversion : show line 1 in the form +6,945 $4.80 $33,336 7,504 D
2024-01-24 Sale : show line 2 in the form −6,945 $20.23 $140,497 559 D
2024-01-24 Exercise or conversion : show line 3 in the form +84,107 $6.15 $517,258 84,666 D
2024-01-24 Sale : show line 4 in the form −84,107 $20.23 $1,701,485 559 D
Open-market sales · 91,052 sh · avg $20.23 · $1,841,982
Loading xslF345X05/ownership.xml…